Stockscreener 앱 받기
1.26
2.33%
-0.03
전일 마감가:
$1.29
열려 있는:
$1.3
하루 거래량:
449.00K
Relative Volume:
0.50
시가총액:
$134.41M
수익:
$45.44M
순이익/손실:
$-35.43M
주가수익비율:
-3.7059
EPS:
-0.34
순현금흐름:
$-25.39M
1주 성능:
-11.89%
1개월 성능:
-14.29%
6개월 성능:
-40.57%
1년 성능:
-73.47%
1일 변동 폭
$1.26
$1.31
1주일 범위
$1.25
$1.43
52주 변동 폭
$1.25
$5.20
맥스사이트 Stock (MXCT) Company Profile
명칭
Maxcyte Inc
전화
301-517-5556
주소
9713 KEY WEST AVENUE,, ROCKVILLE
MXCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.26 | 137.61M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
맥스사이트 Stock (MXCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | 개시 | Stephens | Overweight |
| 2023-11-29 | 개시 | Craig Hallum | Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-24 | 개시 | BTIG Research | Buy |
| 2021-08-24 | 개시 | Cowen | Outperform |
| 2021-08-24 | 개시 | Stephens | Overweight |
| 2021-08-24 | 개시 | Stifel | Buy |
| 2021-08-24 | 개시 | Wedbush | Outperform |
| 2021-08-24 | 개시 | William Blair | Outperform |
모두보기
맥스사이트 주식(MXCT)의 최신 뉴스
Dip Buying: Is INEO forming a breakout patternJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Investor Mood: How interest rate cuts could boost MaxCyte Inc stockQuarterly Profit Report & Community Verified Trade Signals - Bộ Nội Vụ
MaxCyte to join the 2026 G-Rex Grant Tour in Houston - Traders Union
Published on: 2026-01-14 11:01:42 - baoquankhu1.vn
Day Trade: Is MaxCyte Inc stock affected by interest rate hikesOil Prices & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
MaxCyte announces preliminary unaudited fourth quarter and full year 2025 financial results - marketscreener.com
Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results - TradingView — Track All Markets
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - Benzinga
MaxCyte, Inc. (NASDAQ:MXCT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Risk Off: Can TriNet Group Inc. stock maintain growth trajectory2025 Technical Patterns & Fast Entry Momentum Trade Alerts - moha.gov.vn
Will MaxCyte Inc. stock rally after Fed decisionsStop Loss & Weekly Market Pulse Alerts - Улправда
MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments - MSN
MaxCyte: Building the Future of Cell and Gene Therapy Innovation - MSN
MaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street Zen - Defense World
How strong is MaxCyte Inc. stock balance sheet2025 Performance Recap & Community Driven Trade Alerts - Улправда
Is MaxCyte Inc. stock attractive after correctionTrail vs Road Selection & walk-ready comfort choices - ulpravda.ru
Will MaxCyte Inc. stock gain from government policiesTrade Volume Report & Entry and Exit Point Strategies - Улправда
Why MaxCyte Inc. stock remains undervaluedJuly 2025 Trends & Verified Short-Term Trading Plans - Улправда
Aug Outlook: Will MaxCyte Inc. stock gain from government policiesWeekly Trade Report & Risk Managed Investment Entry Signals - Улправда
How sustainable is MaxCyte Inc. stock dividend payout2025 Technical Patterns & Weekly Breakout Stock Alerts - Улправда
Will MaxCyte Inc. stock outperform value stocksWeekly Gains Report & Free Community Supported Trade Ideas - ulpravda.ru
Downgrade Watch: Why retail investors pile into MaxCyte Inc. stockQuarterly Profit Report & Accurate Buy Signal Notifications - ulpravda.ru
MaxCyte (NASDAQ:MXCT) Shares Up 0.7% – Time to Buy? - Defense World
Bear Alert: How strong is MaxCyte Inc stock balance sheet2025 Market Sentiment & Real-Time Volume Analysis - moha.gov.vn
Aug Patterns: Will MaxCyte Inc stock gain from government policiesInflation Watch & Safe Capital Growth Stock Tips - moha.gov.vn
MaxCyte, Inc.Common Stock (NQ: MXCT - FinancialContent
Will MaxCyte Inc. stock attract more institutional investorsBlue Chip Stock Analysis & Free Trading Psychology Coaching - Улправда
Will MaxCyte Inc. stock deliver strong dividend growth2026 world cup usa national team group stage defensive leaders pressing system tactical prediction guide - Улправда
MaxCyte eyes growth in cell engineering for 2026 - Traders Union
MXCT’s price-to-cash ratio: How it affects the stock’s valuation. - uspostnews.com
MaxCyte advances GMP process with KSQ partnership - Traders Union
Activity Recap: Why GIGGU stock appeals to dividend seekersTrade Entry Report & Smart Allocation Stock Reports - moha.gov.vn
Will MaxCyte Inc. stock benefit from sector rotationShare Buyback & Capital Efficient Trade Techniques - Улправда
Why retail investors pile into MaxCyte Inc. stock2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда
Is MaxCyte Inc. stock a bargain at current levels2025 Major Catalysts & Free Long-Term Investment Growth Plans - Улправда
Stock Recap: How buybacks impact MaxCyte Inc. stock valueJuly 2025 Summary & Verified Technical Trade Signals - DonanımHaber
MaxCyte, Inc.(NasdaqGS: MXCT) dropped from NASDAQ Biotechnology Index - marketscreener.com
MaxCyte, Inc. (NASDAQ:MXCT) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
William Blair Downgrades MaxCyte (MXCT) - MSN
Prepare Yourself for Liftoff: MaxCyte Inc (MXCT) - setenews.com
Healthy Upside Potential: MaxCyte Inc (MXCT) - setenews.com
Mirabella Financial Services LLP Has $14.39 Million Stock Position in MaxCyte, Inc. $MXCT - MarketBeat
How MaxCyte Inc. (MYE0) stock compares with market leadersWeekly Stock Report & Smart Swing Trading Techniques - Newser
Is MaxCyte Inc. (MYE0) stock attractive post correction2025 Top Gainers & Daily Price Action Insights - Newser
Can MaxCyte Inc. (MYE0) stock stage a strong rebound this quarterJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - Newser
Is MaxCyte Inc. stock attractive for ETFsTrade Risk Summary & Consistent Return Strategy Ideas - Newser
Why analysts recommend MaxCyte Inc. (MYE0) stockJuly 2025 Trends & Weekly Setup with ROI Potential - Newser
Is MaxCyte Inc. (MYE0) stock dividend growth reliableAnalyst Upgrade & Stepwise Trade Execution Plans - Newser
MaxCyte drives CAR T manufacturing optimization using ExPERT system - Traders Union
Dividend Watch: Why Clearway Energy Inc. (NY4B) stock is upgraded to buyJuly 2025 Volume & Verified Technical Signals - BỘ NỘI VỤ
맥스사이트 (MXCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
맥스사이트 주식 (MXCT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Swirsky Douglas J | CHIEF FINANCIAL OFFICER |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
161,811 |
| Masoud Maher | President and CEO |
Aug 13 '25 |
Buy |
1.37 |
75,000 |
102,915 |
175,000 |
| Erck Stanley C | Director |
Aug 13 '25 |
Buy |
1.37 |
100,000 |
137,220 |
398,328 |
| DOUGLAS RICHARD | Director |
Aug 13 '25 |
Buy |
1.39 |
80,000 |
111,040 |
230,577 |
| Brooke William W | Director |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
150,879 |
0.42%
1.96%
자본화:
|
볼륨(24시간):